Evidence map›Paper›PMID 31650132›Full record

ArticleDeep learning in medical image analysis and multimodal learning for clinical decision support : Third International Workshop, DLMIA 2017, and 7th International Workshop, ML-CDS 2017, held in conjunction with MICCAI 2017 Quebec City, QC,...2017

Quantifying the Impact of Type 2 Diabetes on Brain Perfusion Using Deep Neural Networks.

Behrouz Saghafi, Prabhat Garg, Benjamin C Wagner, S Carrie Smith, Jianzhao Xu, Ananth J Madhuranthakam, Youngkyoo Jung, Jasmin Divers, Barry I Freedman, Joseph A Maldjian and 1 more

Abstract read
In one paragraph

Article in Deep learning in medical image analysis and multimodal learning for clinical decision support : Third International Workshop, DLMIA 2017, and 7th International Workshop, ML-CDS 2017, held in conjunction with MICCAI 2017 Quebec City, QC,..., 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Behrouz SaghafiUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Prabhat GargUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Benjamin C WagnerUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
S Carrie SmithWake Forest School of Medicine, Winston-Salem, NC, USA.
Jianzhao XuWake Forest School of Medicine, Winston-Salem, NC, USA.
Ananth J MadhuranthakamUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Youngkyoo JungWake Forest School of Medicine, Winston-Salem, NC, USA.
Jasmin DiversWake Forest School of Medicine, Winston-Salem, NC, USA.
Barry I FreedmanWake Forest School of Medicine, Winston-Salem, NC, USA.
Joseph A MaldjianUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Albert MontilloUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.

Funding

Cerebrovascular Disease and Cognitive Performance in African AmericansR01NS075107 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DIVERS, JASMIN, FREEDMAN, BARRY IRA · 2011 to 2015
$2.8M
Genetic Determinants of Renal Transplant Survival from African American DonorsR01MD009055 · NIMHD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DIVERS, JASMIN · 2014 to 2018
$2.0M
NIMHD NIH HHS R01 MD009055NINDS NIH HHS R01 NS075107
6 · The paper itself

Abstract

The effect of Type 2 Diabetes (T2D) on brain health is poorly understood. This study aims to quantify the association between T2D and perfusion in the brain. T2D is a very common metabolic disorder that can cause long term damage to the renal and cardiovascular systems. Previous research has discovered the shape, volume and white matter microstructures in the brain to be significantly impacted by T2D. We propose a fully-connected deep neural network to classify the regional Cerebral Blood Flow into low or high levels, given 16 clinical measures as predictors. The clinical measures include diabetes, renal, cardiovascular and demographics measures. Our model enables us to discover any nonlinear association which might exist between the input features and target. Moreover, our end-to-end architecture automatically learns the most relevant features and combines them without the need for applying a feature selection method. We achieved promising classification performance. Furthermore, in comparison with six (6) classical machine learning algorithms and six (6) alternative deep neural networks similarly tuned for the task, our proposed model outperformed all of them.

Identifiers

PMID31650132
PMCPMC6812498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.